27 news items
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
REGN
16 Jun 24
medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases. For more
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
CADL
FGEN
ONCY
12 Jun 24
on innovative solutions, including recent developments coming from Oncolytics
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
CADL
FGEN
ONCY
12 Jun 24
, and aggressive nature. In order to significantly enhance patient health outcomes, several biotech developers are actively working on innovative
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
REGN
11 Jun 24
are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
REGN
SNY
31 May 24
Pharmaceuticals Targets Quality Weight Loss In Latest Obesity Innovation
xfsc679
CRL
IQV
MAIA
31 May 24
in 2023, analysts believe that the innovation driving the sector remains strong.
MAIA Biotechnology
td1k1s6m3jhmdtyu6s7ew0d 0qg54v1g
REGN
31 May 24
genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases
zlfwrgkn2nwus 3ai4jwg
REGN
31 May 24
the Regeneron Genetics Center® and pioneering genetic medicine platforms, enabling us to identify innovative targets
7hfavw8b
REGN
31 May 24
medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases. For more
c93ajymcn01r8076qcz0f21ngc8j3ymhm4pzn41zysq44kubk424he
REGN
31 May 24
platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases. For more
joghhrjid3t48akg n5cl
BHVN
REGN
29 May 24
-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. The company is advancing its innovative portfolio
jtd2lo7c 75vez3gnnl5detd10pgrz71mdefluoi
REGN
23 May 24
of those affected by one of the most serious diseases of our time. Backed by our legacy of scientific innovation and a deep understanding
8z77vm t2o86u
REGN
20 May 24
-powered insights from the Regeneron Genetics Center® and pioneering genetic medicine platforms, enabling us to identify innovative
vmg7smbdrhhf8we1e0784nu iz
REGN
20 May 24
-powered insights from the Regeneron Genetics Center® and pioneering genetic medicine platforms, enabling us to identify innovative targets
hkn7xrn6h3arcoidx3whi
REGN
17 May 24
the $75,000 top award, the George D. Yancopoulos Innovator Award, named in honor of the pioneering drug researcher
e5wc0fc19zadgaomqkcv51n8q9g4jmd8i1xq
REGN
17 May 24
the $75,000 top award, the George D. Yancopoulos Innovator Award, named in honor of the pioneering drug researcher
qn9fnejnvmof2dn6x2fisenhfjmznhrkl2w9r01oot e8zglfcat2x4ai3z8
REGN
17 May 24
. Yancopoulos Innovator Award, named in honor of the pioneering drug researcher and Regeneron co-Founder, Board co-Chair, President and Chief Scientific
uhf6uds7mtdwm0mjdts0m6rn
REGN
13 May 24
the Regeneron Genetics Center® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary
1px8sshyxyc324frgd3mwd2iryr isjyd1hywd7gwysbkckc5hab685q4o
REGN
8 May 24
, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases. For more information, please
x9529c2y 9jnj1vvlbvz
REGN
6 May 24
® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat